Reference number : 236-2013-2014-Q4-00380, amendment number : , agreement type : G, recipient legal name : JASSAL, Sarbijt V, recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : M5G 2C4, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 174168.0, agreement start date : 2014-04-01, agreement end date : 2016-03-31, description english : A pilot study to evaluate the feasibility and safety of performing a double blind, placebo-controlled, randomized controlled trial of The Routine use of SSRIs at the Initiation of End-stage Renal Disease Treatment (ROSIE), description french : A pilot study to evaluate the feasibility and safety of performing a double blind, placebo-controlled, randomized controlled trial of The Routine use of SSRIs at the Initiation of End-stage Renal Disease Treatment (ROSIE), expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2014-15 to 2015-16), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2014-15 à 2015-16), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada